Testosterone replacement therapy in older male subjective memory complainers: Double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety
MetadataShow full item record
© 2015 Bentham Science Publishers. Testosterone replacement therapy (TRT) has been investigated in older men as a preventative treatment against Alzheimer’s disease and dementia. However, previous studies have been contradictory. We assessed TRT physiological effects in 44 older men (aged 61 ± 7.7 years) with subjective memory complaints using a double blind, randomized, crossover, placebo-controlled study. Participants were randomized into 2 groups, one group received transdermal testosterone (50 mg) daily for 24 weeks, followed by a 4 week wash-out period, then 24 weeks of placebo; the other group received the reverse treatment. Blood evaluation revealed significant increases in total testosterone, free (calculated) testosterone, dihydrotestosterone, and a decrease in luteinizing hormone levels (p<0.001) following TRT. Although there were significant increases in red blood cell counts, hemoglobin and prostate specific antigen levels following TRT, they remained within normal ranges. No significant differences in plasma amyloid beta, estradiol, sex hormone binding globulin, insulin levels, body fat percentage, or body mass index were detected. This is the first carefully controlled study that has investigated the influence of TRT in Indonesian men on blood biomarkers linked to dementia risk. Our study suggests TRT is safe and well-tolerated in this Indonesian cohort, yet longitudinal studies with larger cohorts are needed to assess TRT further, and to establish whether TRT reduces dementia risk.
Showing items related by title, author, creator and subject.
Wahjoepramono, E.; Asih, P.; Aniwiyanti, V.; Taddei, K.; Dhaliwal, S.; Fuller, S.; Foster, J.; Carruthers, M.; Verdile, Giuseppe; Sohrabi, H.; Martins, R. (2016)Reduction in testosterone levels in men during aging is associated with cognitive decline and risk of dementia. Animal studies have shown benefits for testosterone supplementation in improving cognition and reducing ...
Perinatal testosterone exposure and cerebral lateralisation in adult males: Evidence for the callosal hypothesisHollier, Lauren; Maybery, M.; Keelan, J.; Hickey, M.; Whitehouse, A. (2014)Two competing theories address the influence of foetal testosterone on cerebral laterality: one proposing exposure to high foetal testosterone concentrations is related to atypical lateralisation (Geschwind–Galaburda ...
Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer.Spry, N.; Kristjanson, Linda; Hooton, B.; Hayden, L.; Neerhut, G.; Gurney, H.; Corica, T.; Korbel, E.; Weinstein, S.; McCaul, Kieran (2006)Health-related quality of life (HQOL) research is a means of broadening the assessment of treatment effects. This longitudinal study investigated the dynamic change to quality of life (QOL) and testosterone dependant ...